LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	NVP-AEW541	0.04	uM	LJP5	2	E18	72	hr	1097	3548	3769	0.9412	0.9171
BT-20	PIK-93	0.04	uM	LJP5	3	K18	72	hr	1097	3796	3769	1.0070	1.0099
BT-20	Barasertib	0.04	uM	LJP5	1	D12	72	hr	1097	2556	3769	0.6781	0.5459
BT-20	NVP-AEW541	0.04	uM	LJP5	1	E18	72	hr	1097	3818	3769	1.0129	1.0181
BT-20	SB590885	0.04	uM	LJP5	2	L18	72	hr	1097	4076	3769	1.0813	1.1147
BT-20	PIK-93	0.04	uM	LJP5	2	K18	72	hr	1097	3871	3769	1.0269	1.0380
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1097	2788	3769	0.7396	0.6327
BT-20	AZD8330	0.04	uM	LJP5	3	G24	72	hr	1097	2766	3769	0.7338	0.6245
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1097	3176	3769	0.8425	0.7779
BT-20	GDC-0980	0.04	uM	LJP5	3	K24	72	hr	1097	1550	3769	0.4112	0.1694
BT-20	NVP-AEW541	0.04	uM	LJP5	3	E18	72	hr	1097	4136	3769	1.0972	1.1371
BT-20	SB590885	0.04	uM	LJP5	1	L18	72	hr	1097	3995	3769	1.0598	1.0844
BT-20	SB590885	0.04	uM	LJP5	3	L18	72	hr	1097	3684	3769	0.9773	0.9680
BT-20	PIK-93	0.04	uM	LJP5	1	K18	72	hr	1097	4020	3769	1.0664	1.0937
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1097	3349	3769	0.8884	0.8426
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1097	3757	3769	0.9967	0.9953
BT-20	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1097	3868	3769	1.0261	1.0368
BT-20	AZD8330	0.04	uM	LJP5	2	G24	72	hr	1097	3012	3769	0.7990	0.7165
BT-20	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	1097	3419	3769	0.9070	0.8688
BT-20	Barasertib	0.04	uM	LJP5	2	D12	72	hr	1097	3022	3769	0.8017	0.7203
BT-20	GDC-0980	0.04	uM	LJP5	1	K24	72	hr	1097	1389	3769	0.3685	0.1092
BT-20	GDC-0980	0.04	uM	LJP5	2	K24	72	hr	1097	1267	3769	0.3361	0.0635
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1097	3395	3769	0.9006	0.8598
BT-20	Alpelisib	0.04	uM	LJP5	1	N06	72	hr	1097	4305	3769	1.1420	1.2004
BT-20	AZD8330	0.04	uM	LJP5	1	G24	72	hr	1097	2849	3769	0.7558	0.6555

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)